News

Data show a nearly 30% reduction in individuals filling naloxone prescriptions at the start of COVID-19 pandemic, with no significant recovery observed.

FIX activity was similar in participants without and with pre-existing neutralizing antibodies.

An electronic reminding system helped identify 3783 patients with anti-HCV antibody documentation.

The low-dose cohort of RP-A501 conferred cardiac LAMP2B transgene expression.

Patients who received 2 mg or 4 mg of baricitinib maintained vIGA-AD scores through 68 weeks of treatment.

Sickle cell patients in rural areas may actually benefit from telemedicine practices and access to satellite clinics.

The treatment shows superior results over bupivacine solution, with a significant number of patients becoming opioid-free.

Prescription rates of buprenorphine and opioid analgesics for OUD fell during the COVID-19 pandemic for new patients, but existing treatment was not affected.

There was no significant association between uric acid levels and incident stroke.

The ortho-k lenses are fitted to a patient's eye using a corneal shape to temporarily reshape the cornea.

Bayer has submitted a New Drug Application for the mineralocorticoid receptor antagonist.

The presence of extra-intestinal manifestations in biologic-naïve anti-TNF patients with Crohn’s disease was a predictor of disease severity.

A new study compares patients self-reported outcomes after depot or daily sublingual buprenorphine treatment, including satisfaction and burden rates.

The majority of adverse effects reported were considered mild.

While obesity is less common in pediatric sickle cell patients, BMI may impact airway resistance in this population.

The smart pen cap system is associated with real-time hypoglycemia alerts and insulin dose recommendations.

A new study presented at ASGCT found that patients with indications of hemostatic efficacy experienced few adverse effects with gene therapy treatment BAY 2599023.

More than 3000 people per day in India have died of COVID-19 since April 28.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Early results from the MOMENTUM study show that treated patients experienced fewer vaso-occlusive episodes and related hospital admissions.

More than 40% of the treatment arm of the placebo-controlled trial achieved a complete renal response.

Histologic scores in the endoscopically involved mucosa of index biopsies not linked to subsequent extension of ulcerative colitis.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

Dr. Todd Hutton gives tips for how to best handle the ongoing mental health crisis.

Research at ARVO 2021 highlighted a gamut of interplaying diabetes and vision loss risk factors, and even treatments for both. But experts depict a referral and care process that lacks whole diabetes care.

A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.

A podcast interview with study author Paul Yang, MD, PhD, on the current research and future implementation of the agent.

Data from the KITE study shows that ≥50% of brolucizumab patients maintained a 12-week interval schedule through 52 weeks.